Misconduct Apology

A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, STEAKPINBALLLast month Paul Muchowksi, a senior researcher at the Gladstone Institute for Neurological Disease, was reprimanded after the Office of Research Integrity (ORI) found that he had reported data that didn’t exist at the time he submitted three grant applications to the National Institutes of Health, one of which was funded. Now, Murchowski has written an open letter of apology and clarification, posted last week (January 9) at Retraction Watch.

In the letter, Murchowski expressed “sincere remorse and apologies” to the scientific community. “In these instances, I stated that the experiments had, in fact, been performed prior to their completion,” he wrote. “Based on previous experience with such experiments, I believed that I could perform these experiments by the time that my grant would be reviewed.” He claimed that the studies in question were not critical in determining the fate of the applications, but wrote that, “I now know with conviction and remorse to only include the data I have at hand and have checked myself.”

Murchowski added that his published findings have never been called into question, that there will be no retractions based on the ORI’s findings, and that the funded grant at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery